MEDCARE TECHNOLOGIES, INC.
    
                    REGULATION D SUBSCRIPTION AGREEMENT
    
     THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED WITH
     THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE OR
     OTHER SECURITIES AUTHORITIES. THEY ARE BEING OFFERED
     PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER
     REGULATION D ("REGULATION "D") PROMULGATED UNDER THE ACT.
     THEY MAY NOT BE SOLD OR TRANSFERRED EXCEPT PURSUANT TO AN
     EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION FROM THE
     REGISTRATION REQUIREMENTS OF THOSE SECURITIES LAWS.
    
     THIS SUBSCRIPTION AGREEMENT DOES NOT CONSTITUTE AN OFFER TO
     SELL, OR A SOLICITATION OF AN OFFER TO PURCHASE, ANY OF THE
     SECURITIES DESCRIBED HEREIN BY OR TO ANY PERSON IN ANY
     JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION WOULD BE
     UNLAWFUL. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY
     ANY FEDERAL OR STATE SECURITIES AUTHORITIES, NOR HAVE SUCH
     AUTHORITIES REVIEWED OR DETERS THE ACCURACY OF THIS
     DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
     OFFENSE.
    
     AN INVESTMENT IN THESE SECURITIES INVOLVES A HIGH DEGREE OF
     RISK. SUBSCRIBERS MUST RELY ON THEIR OWN ANALYSIS OF THE
     INVESTMENT AND ASSESSMENT OF THE RISKS INVOLVED. SEE THE
     RISK FACTORS SET FORTH IN THE ATTACHED DISCLOSURE
     DOCUMENTS AS EXHIBIT I. 

     SEE ADDITIONAL LEGENDS AT SECTIONS 3.7 and 9.
    
     THIS REGULATION D SUBSCRIPTION AGREE (this "Agreement") is made as of the 
20th day of June, 1997, by and between Medcare Technologies, Inc., a corporation
duly organized and existing under the laws of the State of Delaware (the 
"Company"), and the undersigned subscriber executing this Agreement 
("Subscriber"). 
    
     THE PARTIES HEREBY AGREE AS FOLLOWS:
    
     This Agreement is executed by Subscriber in connection with the offer by 
the Company and the purchase by Subscriber of Series A Preferred Stock, $.25 
par value (the "Preferred Stock"), of the Company. The Preferred Stock is being 
offered at a purchase price of Ten Thousand Dollars ($10,000), U.S., per share, 
in minimum subscription amounts of at least ten (10) shares ($100,000), and 
increments of five (5) shares ($50,000) in excess thereof, with a minimum 
aggregate offering amount of One Hundred Ninety (190) shares of Preferred Stock,
or One Million Nine Hundred Thousand Dollars ($1,900,000) (the "Minimum 
Amount"), and up to a maximum aggregate amount of Three Hundred (300) shares of 
Preferred Stock. or Three Million Dollars ($3,000,000) (the "Maximum Amount") 
(collectively, the "Offering"). The terms of the Preferred Stock, including the
terms on which the Preferred Stock may be converted into common stock, $.001 par
value, of the Company (the "Common Stock"), are set forth in the Certificate of 
Designation of Series A Preferred Stock (the "Certificate of Designation"), 
substantially in the form attached hereto as Exhibit A. The Preferred Stock is 
accompanied by (i) a warrant or warrants to purchase a number of shares of
Common Stock of the Company equal to thirty-three and one-third percent 
(33 1/3%) multiplied by the aggregate purchase price of the Subscriber's 
Preferred Stock     

<PAGE>

outstanding on the date which is nine (9) months following the closing hereunder
divided by the Fixed Conversion Price, as defined in the Certificate of 
Designation (the "Nine Month Warrants"); (ii) a warrant or warrants to purchase 
a number of shares of Common Stock of the Company equal to thirty-three and 
one-third percent (33 1/3%) multiplied by the aggregate purchase price of the
Subscriber's Preferred Stock outstanding on the date which is twelve (12) months
following the closing hereunder divided by the Fixed Conversion Price, as 
defined in the Certificate of Designation (the "Twelve Month Warrants"); and 
(iii) a warrant or warrants to purchase a number of shares of Common Stock of 
the Company equal to thirty-three and one-third percent (33 1/3%) multiplied by
the aggregate purchase price of the Subscriber's Preferred Stock outstanding on 
the date which is fifteen ( 15) months following the closing hereunder divided 
by the Fixed Conversion Price, as defined in the Certificate of Designation (the
"Fifteen Month Warrants"). The terms of the Nine Month Warrants, including the 
terms on which the Nine Month Warrants may be exercised for Common Stock, are 
set forth in the form of the Nine Month Warrants attached hereto as Exhibit B.
The terms of the Twelve Month Warrants, including the terms on which the Twelve 
Month Warrants may be exercised for Common Stock, are set forth in the form of 
the Twelve Month Warrants attached hereto as Exhibit C. The terms of the Fifteen
Month Warrants, including the terms on which the Fifteen Month Warrants may be 
exercised for Common Stock, are set forth in the form of the Fifteen Month 
Warrants attached hereto as Exhibit D. The Nine Month Warrants, the Twelve Month
Warrants, and the Fifteen Month Warrants are hereinafter referred to 
collectively as the "Conversion Warrants." The Preferred Stock is also 
accompanied by a warrant or warrant to purchase, anytime during the first twelve
( 12) months following the Last Closing, as that term is defined in Section
4.12 below, a number of additional shares of Preferred Stock up to the number 
purchased by Subscriber in the Offering (the "Preferred Warrants") . The 
Conversion Warrants and the Preferred Warrants may be referred to hereinafter as
the "Warrants." The terms of the Preferred Warrants, including the terms on 
which the Preferred Warrants may be exercised for Preferred Stock, are set
forth in the form of the Preferred Warrants attached hereto as Exhibit E.  The 
solicitation of this subscription and, if accepted by the Company, the offer and
sale of the Preferred Stock are being made in reliance upon the provisions of 
Regulation D ("Regulation D") promulgated under the Securities Act of 1933, as 
amended ("the Act"). The Preferred Stock, including the Preferred Stock issued 
upon exercise of the Preferred Warrants, and the Common Stock issuable upon 
conversion thereof (the "Conversion Shares"), together with the Conversion 
Warrants and the Common Stock issuable upon exercise thereof (the "Warrant 
Shares") and the Preferred Warrants, are sometimes referred to herein singularly
as "Security" and collectively as the "Securities."     

    It is agreed as follows:
    
    1.   OFFERING
    
    1.1   OFFER TO SUBSCRIBE: PURCHASE PRICE AND CLOSING: AND PLACEMENT
FEES.
    
      Subject to satisfaction of the conditions to closing set forth in Section 
1.2 below, Subscriber hereby offers to subscribe for and purchase Preferred 
Stock and accompanying Warrants, for the aggregate purchase price in the amount 
set forth in Section 10 of this Agreement, in accordance with the terms and 
conditions of this Agreement. Assuming that the Minimum Amount and corresponding
subscription agreements accepted by the Company are received into the Company's 
designated escrow account for this Offering established pursuant to the Escrow 
Agreement and Instructions (the "Escrow Agreement") by and among the Company, 
First Union National Bank of Georgia (the "Escrow Agent") and the Placement 
Agent (as defined below) (the "Escrow Account"), the closing of a sale and 
purchase of Preferred Stock as to each Subscriber (the "Closing") shall be 
deemed to occur when this Agreement has been executed by both Subscriber and the
Company and full payment shall have been made by Subscriber, by wire transfer to
the Escrow Account as set forth in Section 7.1(a) for payment in consideration 
for the Company's delivery of certificates representing the Preferred Stock 
subscribed for. 

                                       2
<PAGE>
    
The parties hereto acknowledge that Swartz Investments, LLC is acting as 
placement agent (the "Placement Agent") for this Offering and will be 
compensated by the Company in cash and warrants to purchase Common Stock. The 
Placement Agent has acted solely as placement agent in connection with the 
Offering by the Company of the Preferred Stock pursuant to this Agreement. The
information and data contained in the Disclosure Documents (as defined in 
Section 2.2.4) have not been subjected to independent verification by the 
Placement Agent, and no representation or warranty is made by the Placement 
Agent as to the accuracy or completeness of the information contained in the 
Disclosure Documents.
    
The Company and Subscriber acknowledge that the Matthew Fund, N.V. (the "Fund"),
which is managed by affiliates of the Placement Agent, may subscribe for 
securities in the Offering. The parties acknowledge that neither the Placement 
Agent nor any of its affiliates shall be under any obligation to advise the 
Company or Subscriber of the activities of the Fund with respect to such
securities following the consummation of the Offering. Such acknowledgment shall
not act as a waiver of any obligation required by law or written agreement of 
which the Fund is a party. It is understood that the Fund will act independently
of the Placement Agent and may take action with respect to such investment which
may be inconsistent or contrary to any action or interest of the Placement 
Agent, the Company or any of the other Subscribers. 
     
      1.2    CONDITIONS TO SUBSCRIBER'S OBLIGATIONS. Subscriber's obligations 
hereunder are conditioned upon all of the following:
    
      (a)  the following documents shall have been deposited with the Escrow 
Agent the Registration Rights Agreement, substantially in the form attached 
hereto as Exhibit F (the "Registration Rights Agreement") (executed by the 
Company), an opinion of counsel, substantially in the form attached hereto as 
Exhibit G (the "Opinion of Counsel") (signed by the Company's counsel), the 
Irrevocable Instructions to Transfer Agent, substantially in the form attached 
hereto as Exhibit H (the "Irrevocable Instructions to Transfer Agent" executed 
by the Company and the Company's transfer agent [the "Transfer Agent"]), and the
Certificate of Designation, substantially in the form attached hereto as Exhibit
A (together with evidence showing that it has been filed with the Secretary of 
State of Delaware); certificates representing the Preferred Stock issued in the 
name of the Subscriber, the Conversion Warrants and the Preferred Warrants 
issued in the name of the Subscriber;
    
       (b)  the Company's Common Stock shall be listed for and actively trading 
on the OTC Bulletin Board;
    
       (c) other than losses described in the Risk Factors as set forth in 
Section 2.2.4 below there have been no material adverse changes in the Company's
business prospects or financial condition since the date of the last balance 
sheet included in the Disclosure Documents (defined below in Section 2.2.4), 
including but not limited to incurring material liabilities;
    
       (d) the representations and warranties of the Company are true and 
correct in all material respects at the Closing as if made on such date, and the
Company shall deliver a certificate, signed by an officer of the Company, to 
such effect to the Escrow Agent;
    
       (e) the Minimum Amount and corresponding subscription agreements accepted
by the Company shall have been received by the Escrow Agent; and

                                                                    3
<PAGE>
       (f)   the Company shall have reserved for issuance a sufficient number of
shares of Common Stock to effect conversions of the Preferred; Stock, including 
Preferred Stock issued upon exercise of the Preferred Warrants, and exercise of 
the Conversion Warrants, which number of shares shall initially be equal to one 
million five hundred thousand ( 1,500,000) shares.
    
    2.   REPRESENTATIONS AND WARRANTIES OF SUBSCRIBER. Subscriber hereby 
represents and warrants to the Company as follows:
    
      2.1  ACCREDITED INVESTOR. Subscriber is an accredited investor, as defined
in Rule 501 of Regulation D, and has checked the applicable box set forth in 
Section 10 of this Agreement. 
    
      2.2  INVESTMENT EXPERIENCE; ACCESS TO INFORMATION; INDEPENDENT 
INVESTIGATION.
    
           2.2.1 ACCESS TO INFORMATION. Subscriber or Subscriber's professional 
advisor has been granted the opportunity to ask questions of and receive answers
from representatives of the Company, its officers, directors, employees and 
agents concerning the terms and conditions of this Offering, the Company and its
business and prospects, and to obtain any additional information which 
Subscriber or Subscriber's professional advisor deems necessary to verify the 
accuracy and completeness of the information received. 
    
          2.2.2 RELIANCE ON OWN ADVISORS. Subscriber has relied completely on 
the advice of, or has consulted with, Subscriber's own personal tax, investment,
legal or other advisors and has not relied on the Company or any of its 
affiliates, officers, directors, attorneys, accountants or any affiliates of any
thereof and each other person, if any, who controls any thereof, within the 
meaning of Section I 5 of the Act for any tax or legal advice (other than 
reliance on information in the Disclosure Documents as defined in Section 2.2.4 
below and on the Opinion of Counsel). The foregoing, however, does not limit or 
modify Subscriber's right to rely upon representations and warranties of the 
Company in Section 4 of this Agreement. 
    
          2.2.3 CAPABILITY TO EVALUATE. Subscriber has such knowledge and 
experience in financial and business matters so as to enable such Subscriber to 
utilize the information made available to it in connection with the Offering in 
order to evaluate the merits and risks of the prospective investment, which are 
substantial, including without limitation those set forth in the Disclosure
Documents (as defined in Section 2.2.4 below).
    
          2.2.4 DISCLOSURE DOCUMENTS. Subscriber, in making Subscriber's 
investment decision to subscribe for the Securities hereunder, represents that 
(a) Subscriber has received and had an opportunity to review (i) the Company's 
Annual Report on Form 10-K for the year ended December 31, 1996 (ii) the 
Company's quarterly report on Form I0-Q for the quarters ended March 31, 1997,
(iii) the Risk Factors, attached as Exhibit I, (iv) the Capitalization Schedule,
attached as Exhibit I, (the "Capitalization Schedule") and (v) the Use of 
Proceeds Schedule, attached as Exhibit K, (the "Use of Proceeds Schedule") (b) 
Subscriber has read, reviewed, and relied solely on the documents described in 
(a) above, the Company's representations and warranties and other information in
this Agreement, including the exhibits, any other written information prepared 
by the Company which has been specifically provided to Subscriber in connection 
with this Offering (the documents described in Section 2.2.4 (a) and (b) are 
collectively referred to as the "Disclosure Documents"), and an independent 
investigation made by Subscriber and Subscriber's representatives, if any; (c)
Subscriber has, prior to the date of this Agreement, been given an opportunity 
to review material contracts and documents of the Company which have been filed 
as exhibits to the Company's filings under the Act and the Securities Exchange 
Act of 1934, as amended (the "Exchange Act") and has had an opportunity to ask 
questions of and receive answers from the Company's officers and directors; and 
(d) is not relying 
                                          4
<PAGE>
    
on any oral representation of the Company or any other person, nor any written 
representation or assurance from the Company other than those referred to in 
Section 4 or otherwise contained in the Disclosure Documents or incorporated 
herein or therein. The foregoing, however, does not limit or modify Subscriber's
right to rely upon representations and warranties of the Company in Section 4
4 of this Agreement. Subscriber acknowledges and agrees that the Company has no 
responsibility for, does not ratify, and is under no responsibility whatsoever 
to comment upon or correct any reports, analyses or other comments made about 
the Company by any third parties, including, but not limited to, analysts' 
research reports or comments (collectively, "Third Party Reports"), and
Subscriber has not relied upon any Third Party Reports, including any provided 
by the Placement Agent, in making the decision to invest.
    
         2.2.5   INVESTMENT EXPERIENCE; FEND FOR SELF. Subscriber has 
substantial experience in investing in securities and has made investments in 
securities other than those of the Company. Subscriber acknowledges that 
Subscriber is able to fend for Subscriber's self in the transaction contemplated
by this Agreement, that Subscriber has the ability to bear the economic risk of
Subscriber's investment pursuant to this Agreement and that Subscriber is an 
"Accredited Investor" by virtue of the fact that Subscriber meets the investor 
qualification standards set forth in Section 2.1 above. Subscriber has not been 
organized for the purpose of investing in securities of the Company, although 
such investment is consistent with Subscriber's purposes.
    
    2.3   EXEMPT OFFERING UNDER REGULATION D.
    
         2.3.1 INVESTMENT; NO DISTRIBUTION. Subscriber is acquiring the 
Securities solely for Subscriber's own account for investment purposes as a 
principal and not with a view to immediate resale or distribution of all or any 
part thereof. Subscriber is aware that there are legal and practical limits on 
Subscriber's ability to sell or dispose of the Securities and, therefore, that 
Subscriber must bear the economic risk of the investment for an indefinite 
period of time and has adequate means of providing for Subscriber's current 
needs and possible personal contingencies and has need for only limited 
liquidity of this investment. Subscriber's commitment to illiquid investments is
reasonable in relation to Subscriber's net worth. By making the representations 
in this Section 2.3.1, the Subscriber does not agree to hold the Securities for 
any minimum or other specific term and reserves the right to dispose of the 
Securities at any time in accordance with or pursuant to a registration
statement or an exemption from registration under the Act, except as otherwise 
required in this Agreement or in the Registration Rights Agreement.
    
         2.3.2  NO GENERAL SOLICITATION. The Securities were not offered to 
Subscriber through, and Subscriber is not aware of, any form of general 
solicitation or general advertising, including, without limitation, (i) any 
advertisement, article, notice or other communication published in any
newspaper, magazine or similar media or broadcast over television or radio, and 
(ii) any seminar or meeting whose attendees have been invited by any general 
solicitation or general advertising.
    
         2.3.3  RESTRICTED SECURITIES. Subscriber understands that the Preferred
Stock issued at Closing. the Preferred Warrants, and the Conversion Warrants 
are, and the Conversion Shares and the Preferred Stock issued upon exercise of 
the Preferred Warrants will be, characterized as "restricted securities" under 
the federal securities laws inasmuch as they are being acquired from the
Company in a transaction not involving a public offering and that under such 
laws and applicable regulations such securities may not be transferred or resold
without registration under the Act or pursuant to an exemption therefrom. In 
this connection, Subscriber represents that Subscriber is familiar with Rule 144
under the Act, as presently in effect, and understands the resale limitations 
imposed thereby and by the Act. 
                                  5
<PAGE>
         2.3.4  DISPOSITION. Without in any way limiting the representations set
forth above, Subscriber further agrees not to make any disposition of all or any
portion of the Securities unless and until: 
    
            (a)  There is then in effect a registration statement under the Act 
      covering such proposed disposition and such disposition is made in 
      accordance with such registration statement; or 
    
            (b)  (i) Subscriber shall have notified the Company of the proposed 
      disposition and shall have furnished the Company with a detailed statement
      of the circumstances surrounding the proposed disposition, and (ii) if 
      reasonably requested by the Company, Subscriber shall have furnished the
      Company with an opinion of counsel, reasonably satisfactory to the 
      Company, that such disposition will not require registration of the 
      Securities under the Act. It is agreed that the Company will not require 
      opinions of counsel for transactions made pursuant to Rule 144 except in 
      unusual circumstances.
    
    2.4 DUE AUTHORIZATION.
    
         2.4.1  AUTHORITY. Subscriber, if executing this Agreement in a 
representative or fiduciary capacity, has full power and authority to execute 
and deliver this Agreement and each other document included herein for which a 
signature is required in such capacity and on behalf of the subscribing 
individual, partnership, trust, estate, corporation or other entity for whom or 
which Subscriber is executing this Agreement. Subscriber has reached the age of 
majority (if an individual) according to the laws of the state in which he 
resides, has adequate means for providing for his current needs and personal 
contingencies, is able to bear the economic risk of his investment in the
Securities for an indefinite period of time and could afford a complete loss of 
such investment. Subscriber's commitment to illiquid investments is reasonable 
in relation to Subscriber's net worth.
    
         2.4.2  DUE AUTHORIZATION. If Subscriber is a corporation, Subscriber is
duly and validly organized, validly existing and in good tax and corporate 
standing as a corporation under the laws of the jurisdiction of its 
incorporation with full power and authority to purchase the Securities to be
purchased by Subscriber and to execute and deliver this Agreement. 
    
         2.4.3  PARTNERSHIPS. If Subscriber is a partnership, the 
representations, warranties, agreements and understandings set forth above are 
true with respect to all partners of Subscriber (and if any such partner is 
itself a partnership, all persons holding an interest in such partnership, 
directly or indirectly, including through one or more partnerships), and the 
person executing this Agreement has made due inquiry to determine the 
truthfulness of the representations and warranties made hereby.
    
         2.4.4  REPRESENTATIVES. If Subscriber is purchasing in a representative
or fiduciary capacity, the representations and warranties shall be deemed to 
have been made on behalf of the person or persons for whom Subscriber is so 
purchasing.
    
    3.  ACKNOWLEDGMENTS.  Subscriber is aware that:
    
         3.1  RISKS OF INVESTMENT. Subscriber recognizes that an investment in 
the Company involves substantial risks, including the potential loss of 
Subscriber's entire investment herein.  Subscriber recognizes that this 
Agreement and the exhibits hereto do not purport to contain all the information 
which would be contained in a registration statement under the Act;
    
                                        6
<PAGE>   

         3.2  NO GOVERNMENT APPROVAL. No federal or state agency has passed upon
the securities or made any finding or determination as to the fairness of this 
transaction;
    
         3.3  NO REGISTRATION. The Securities and any component thereof have not
been registered under the Act or any applicable state securities laws by reason 
of exemptions from the registration requirements of the Act and such laws, and 
may not be sold, pledged, assigned or otherwise disposed of in the absence of 
an effective registration of the Securities and any component thereof under the
Act or unless an exemption from such registration is available;
    
         3.4  RESTRICTIONS ON TRANSFER. Subscriber may not attempt to sell, 
transfer, assign, pledge or otherwise dispose of all or any portion of the 
Securities or any component thereof in the absence of either an effective 
registration statement or an exemption from the registration requirements of
the Act and applicable state securities laws;
    
         3.5  NO ASSURANCES OF REGISTRATION. There can be no assurance that any 
registration statement will become effective at the scheduled time. Therefore, 
Subscriber may bear the economic risk of Subscriber's investment for an 
indefinite period of time;
    
         3.6  EXEMPT TRANSACTION. Subscriber understands that the Securities are
being offered and sold in reliance on specific exemptions from the registration 
requirements of federal and state law and that the representations, warranties, 
agreements, acknowledgments and understandings set forth herein are being relied
upon by the Company in determining the applicability of such exemptions and the 
suitability of Subscriber to acquire such Securities;
    
         3.7  LEGENDS. It is understood that the certificates evidencing the 
Preferred Stock, including the Preferred Stock issued upon exercise of the 
Preferred Warrants, the Preferred Warrants, the Conversion Warrants, the 
Conversion Shares and the Warrant Shares shall bear the following legend (the 
"Legend") (prior to registration as provided in Section 5.1):
    
          "The securities represented hereby have not been registered under the 
          Securities Act of 1933, or applicable state securities laws, nor the 
          securities laws of any other jurisdiction. They may not be sold or 
          transferred in the absence of an effective registration statement 
          under those securities laws or pursuant to an exemption therefrom."
    
    4.    REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company hereby
makes the following representations and warranties to Subscriber (which shall 
be true at the signing of this Agreement, as of Closing, and as of any such 
later date as contemplated hereunder) and agrees with Subscriber that:
    
         4.1  ORGANIZATION, GOOD STANDING. AND QUALIFICATION. The Company is a
corporation duly organized, validly existing and in good standing under the laws
of the State of Delaware USA and has all requisite corporate power and authority
to carry on its business as now conducted and as proposed to be conducted. The 
Company is duly qualified to transact business and is in good standing in each 
jurisdiction in which the failure to so qualify would have a material adverse 
effect on the business or properties of the Company and its subsidiaries taken 
as a whole.  The Company is not the subject of any pending, threatened or, to 
its knowledge, contemplated investigation or administrative or legal proceeding 
by the Internal Revenue Service, the taxing authorities of any state or local 
jurisdiction, or the Securities and Exchange Commission ("SEC"), or any state 
securities commission, or any other governmental entity, which have not been 
disclosed in the Disclosure Documents.
    
         4.2  CORPORATE CONDITION. The Company's condition is, in all material 
respects, as described in the Disclosure Documents, except for changes in the 
ordinary course of business and 
    
                                   7
<PAGE>
    
normal year-end adjustments that are not, in the aggregate, materially adverse 
to the Company.  There have been no material adverse changes to the Company's 
business, financial condition, prospects since the date of such reports. The 
financial statements contained in the Disclosure Documents have been prepared 
in accordance with generally accepted accounting principles, consistently 
applied (except as otherwise permitted by Regulation S-X of the Exchange Act), 
and fairly present the consolidated financial condition of the Company as of the
dates of the balance sheets included therein and the consolidated results of its
operations and cash flows for the periods then ended. Without limiting the 
foregoing, there are no material liabilities, contingent or actual, that are not
disclosed in the Disclosure Documents (other than liabilities incurred by the 
Company in the ordinary course of its business, consistent with its past 
practice, after the period covered by the Disclosure Documents). The Company has
paid all material taxes which are due, except for taxes which it reasonably 
disputes. There is no material claim, litigation, or administrative proceeding
pending, or, to the best of the Company's knowledge, threatened against the 
Company, except as disclosed in the Disclosure Documents. This Agreement and the
Disclosure Documents do not contain any untrue statement of a material fact and 
do not omit to state any material fact required to be stated therein or herein 
necessary to make the statements contained therein or herein not misleading in 
the light of the circumstances under which they were made. 
    
    4.3  AUTHORIZATION. Except for the filing of the Certificate of Designation,
all corporate action on the part of the Company by its officers, directors and 
shareholders necessary for the authorization, execution and delivery of this 
Agreement, the performance of all obligations of the Company hereunder and the 
authorization, issuance and delivery of the Preferred Stock being sold hereunder
and the issuance (and/or the reservation for issuance) of the Conversion Shares,
the Preferred Warrants, the Conversion Warrants, the Warrant Shares and the 
Preferred Stock to be issued upon exercise of the Preferred Warrants, have been 
taken, and this Agreement, the Certificate of Designation, the Irrevocable 
Instructions to Transfer Agent, the Escrow Agreement and the Registration Rights
Agreement constitute valid and legally binding obligations of the Company,
enforceable in accordance with their terms, except insofar as the enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, or other 
similar laws affecting creditors' rights generally or by principles governing 
the availability of equitable remedies. The Company has obtained all consents 
and approvals required for it to execute, deliver and perform each agreement
referenced in the previous sentence.
    
         4.4  VALID ISSUANCE OF PREFERRED STOCK AND COMMON STOCK.  The Preferred
Stock, and the Preferred Warrants and the Conversion Warrants, when issued, sold
and delivered in accordance with the terms hereof, for the consideration 
expressed herein, will be validly issued, fully paid and nonassessable and, 
based in part upon the representations of Subscriber in this Agreement, will be 
issued in compliance with all applicable U.S. federal and state securities laws.
The Conversion Shares and the Warrant Shares and the Preferred Stock issued upon
exercise of the Preferred Warrants, when issued in accordance with the terms of 
the Certificate of Designation or the Conversion Warrants or the Preferred 
Warrants, as applicable, shall be duly and validly issued and outstanding, fully
paid and nonassessable, and based in part on the representations and warranties 
of Subscriber of the Preferred Stock, will be issued in compliance with all 
applicable U.S. federal and state securities laws. The Preferred Stock, the 
Conversion Shares, the Conversion Warrants, the Preferred Warrants, and the 
Warrant Shares will be issued free of any preemptive rights. The Company 
currently has one million five hundred thousand (1,500,000) Conversion Shares 
reserved for issuance upon conversion of the Preferred Stock, including 
Preferred Stock issued upon exercise of the Preferred Warrants, and upon 
exercise of the Conversion Warrants.
    
         4.5  COMPLIANCE WITH OTHER INSTRUMENTS. The Company is not in violation
or default of any provisions of its Certificate of Incorporation or Bylaws as 
amended and in effect on and as of the date of the Agreement or of any material 
provision of any material instrument or contract to which it is a party or by 
which it is bound or, to its knowledge, of any provision of any 
    
                                          8
<PAGE> 

federal or state judgment, writ, decree, order, statute, rule or governmental 
regulation applicable to the Company, which would have a material adverse 
affect on the Company's business or prospects, except as described in the 
Disclosure Documents. The execution, delivery and performance of this Agreement 
and the other agreements entered into in conjunction with the Offering and the
consummation of the transactions contemplated hereby will not result in any such
violation or be in conflict with or constitute, with or without the passage of 
time and giving of notice, either a default under any such provision, instrument
or contract or an event which results in the creation of any lien, charge or 
encumbrance upon any assets of the Company.  
    
         4.6  REPORTING COMPANY. The Company is subject to the reporting 
requirements of the Exchange Act, has a class of securities registered under 
Section 12 of the Exchange Act, and has filed all reports required by the 
Exchange Act since November 13, 1996. The Company undertakes to furnish 
Subscriber with copies of such reports as may be reasonably requested by 
Subscriber prior to consummation of this Offering and thereafter as long as 
Subscriber holds the Securities. The Company is not in violation of the listing 
requirements of the OTC Bulletin Board and does not reasonably anticipate that 
the Common Stock will be delisted by the OTC Bulletin Board for the foreseeable 
future.
    
         4.7  CAPITALIZATION. The capitalization of the Company as of March 31, 
1997, is, and the capitalization as of the Closing, after taking into account 
the offering of the Securities contemplated by this Agreement and all other 
share issuances occurring prior to this Offering, will be, as set forth in the 
Capitalization Schedule as set forth in Exhibit 1. Except as disclosed in the 
Capitalization Schedule, as of the date of this Agreement, (i) there are no 
outstanding options, warrants, scrip, rights to subscribe for, calls or 
commitments of any character whatsoever relating to, or securities or rights 
convertible into or exercisable or exchangeable for, any shares of capital stock
of the Company or any of its subsidiaries, or arrangements by which the Company 
or any of its subsidiaries is or may become bound to issue additional shares of 
capital stock of the Company or any of its subsidiaries, and (ii) there are no 
agreements or arrangements under which the Company or any of its subsidiaries is
obligated to register the sale of any of its or their securities under the Act 
(except the Registration Rights Agreement).
    
         4.8  INTELLECTUAL PROPERTY. The Company has valid, unrestricted and 
exclusive patents, trademarks, trademark registrations, trade names, copyrights,
know-how, technology and other intellectual property necessary to the conduct of
its business as set forth on Exhibit L-l. The Company has granted such licenses 
or has assigned or otherwise transferred a portion of (or all of) such valid, 
unrestricted and exclusive patents, trademarks, trademark registrations, trade 
names, copyrights, know-how, technology and other intellectual property 
necessary to the conduct of its business as set forth on Exhibit L-2. The 
Company has been granted licenses, know-how, technology and/or other 
intellectual property necessary to the conduct of its business as set forth on 
Exhibit L-3. To the best of the Company's knowledge, the Company is not 
infringing on the intellectual property rights of any third party, nor is any 
third party infringing on the Company's intellectual property rights. There are 
no restrictions in any agreements, licenses, franchises, or other instruments 
which preclude the Company from engaging in its business as presently conducted.
   
         4.9  USE OF PROCEEDS. As of the date hereof, the Company expects to use
the proceeds from this Offering (less fees and expenses) for the purposes and in
the approximate amounts set forth on the Use of Proceeds Schedule set forth as 
Exhibit K hereto. These purposes and amounts are estimates and are subject to 
change without notice to any Subscriber.  
    
         4.10  NO RIGHTS OF PARTICIPATION. No person or entity, including, but 
not limited to, current or former shareholders of the Company, underwriters, 
brokers, agents or other third parties, has any right of first refusal, 
preemptive right, right of participation, or any similar right to participate 
in the financing contemplated by this Agreement which has not been waived.
    
                                                                    9
<PAGE>

         4.11  COMPANY ACKNOWLEDGMENT. The Company hereby acknowledges that 
Subscriber may elect to hold the Securities for various periods of time, as 
permitted by the terms of this Agreement, the Certificate of Designation, the 
Conversion Warrants, the Preferred Warrants and other agreements contemplated 
thereby, and the Company further acknowledges that Subscriber and the
Placement Agent have made no representations or warranties, either written or 
oral, as to how long the Securities will be held by Subscriber or regarding 
Subscriber's trading history or investment strategies.
    
         4.12  TERMINATION DATE OF OFFERING. In no event shall the last Closing 
("Last Closing") of a sale and purchase of the Preferred Stock and accompanying 
Conversion Warrants and Preferred Warrants occur later than July 15, 1997, which
date can be extended by up to ten (10) days upon written approval by the Company
and the Placement Agent.
    
         4.13  UNDERWRITER'S FEES AND RIGHTS OF FIRST REFUSAL. The Company is 
not obligated to pay any compensation or other fees, costs or related 
expenditures in cash or securities to any underwriter, broker, agent or other 
representative other than the Placement Agent in connection with this Offering. 
    
         4.14  CURRENT PUBLIC INFORMATION. The Company is currently eligible to 
register the resale of its Common Stock on a registration statement on Form S-1 
under the Act. 
    
         4.15  NO INTEGRATED OFFERING. Neither the Company, nor any of its 
affiliates, nor any person acting on its or their behalf, has directly or 
indirectly made any offers or sales of any security or solicited any offers to 
buy any security under circumstances that would prevent the parties hereto from
consummating the transactions contemplated hereby pursuant to an exemption from
registration under the Act pursuant to the provisions of Regulation D.
    
         4.16  ACKNOWLEDGMENT OF DILUTION. The number of Conversion Shares 
issuable upon conversion of the Preferred Stock may increase substantially in 
certain circumstances, including the circumstance wherein the trading price of 
the Common Stock declines. The Company's executive officers and directors have 
studied and fully understand the nature of the Securities being sold hereunder 
and recognize that they have a potential dilutive effect. The board of directors
of the Company has concluded in its good faith business Judgment that such 
issuance is in the best interests of the Company. The Company acknowledges 
that its obligation to issue Conversion Shares upon conversion of the Preferred 
Stock is binding upon it and enforceable regardless of the dilution that such
issuance may have on the ownership interests of the other stockholders.
    
         4.17  FOREIGN CORRUPT PRACTICES. Neither the Company, nor any of its 
subsidiaries, nor any director, officer, agent, employee or other person acting 
on behalf of the Company or any subsidiary has, in the course of its actions 
for, or on behalf of, the Company, used any corporate funds for any unlawful 
contribution, gift, entertainment or other unlawful expenses relating to
political activity: made any direct or indirect unlawful payment to any foreign 
or domestic government official or employee from corporate funds; violated or is
in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977,
as amended; or made any bribe, rebate, payoff, influence payment, kickback or 
other unlawful payment to any foreign or domestic government official or 
employee.
    
         4.18  KEY EMPLOYEES. Each Key Employee(as defined belong) is currently 
serving the Company in the capacity disclosed in Exhibit M. No Key Employee, to 
the best knowledge of the Company and its subsidiaries. is, or is now expected 
to be, in violation of any material term of any employment contract, 
confidentiality, disclosure or proprietary information agreement, 
non-competition agreement, or any other contract or agreement or any restrictive
covenant, and the 
    
                                 10
<PAGE>

continued employment of each Key Employee does not subject the Company or any of
its subsidiaries to any liability with respect to any of the foregoing matters. 
No Key Employee has, to the best knowledge of the Company and its subsidiaries, 
any intention to terminate his employment with, or services to, the Company or 
any of its subsidiaries. "Key Employee" means each of Harmel Rayat and Valerie 
Boeldt-Umbright.  
    
         4.19  REPRESENTATIONS CORRECT. The foregoing representations, 
warranties and agreements are true, correct and complete in all material 
respects, and shall survive the Closing and the issuance of the shares of 
Preferred Stock.
    
    5.  COVENANTS OF THE COMPANY
    
         5.1  DEPENDENT AUDITORS. The Company shall, until at least three (3) 
years after the date of the Last Closing, maintain as its independent auditors 
an accounting firm authorized to practice before the SEC.
    
         5.2  CORPORATE EXISTENCE AND TAXES. The Company shall, until at least 
after the later of (i) the date that is three (3) years after the date of the 
Last Closing or (ii) the conversion or redemption of all of the Preferred Stock 
purchased pursuant to this Agreement, including Preferred Stock issued upon 
exercise of the Preferred Warrants, and the exercise of the Conversion Warrants,
maintain its corporate existence in good standing (provided, however, that the 
foregoing covenant shall not prevent the Company from entering into any merger 
or corporate reorganization as long as the surviving entity in such transaction,
if not the Company, assumes the Company's obligations with respect to the 
Preferred Stock and has Common Stock listed for trading on a stock exchange
or on Nasdaq and is a "Reporting Issuer") and shall pay all its taxes when due 
except for taxes which the Company disputes.
    
         5.3  REGISTRATION RIGHTS. The Company will enter into a registration 
rights agreement covering the resale of the Conversion Shares and the Warrant 
Shares substantially in the forth of the Registration Rights Agreement attached 
as Exhibit F.
    
         5.4  NOTIFICATION OF FINAL CLOSING DATE BY COMPANY. Within five (5) 
business days after the Last Closing, the Company shall notify Subscriber in 
writing that the Last Closing has occurred, the date of the Last Closing, the 
dates that Subscriber is entitled to convert Subscriber's Preferred Stock, the 
value of the Fixed Conversion Price, as that term is defined in the Certificate
of Designation, and the name and telephone number of an administrative contact 
person at the Company whom Subscriber may contact regarding information related 
to conversion of the Preferred Stock as contemplated by the Certificate of 
Designation.
    
         5.5  FILING OF S-1 REGISTRATION STATEMENT. The Company shall, no later 
than sixty (60) days after the Last Closing, file a registration statement (the 
"Registration Statement") on Form S-l (or other suitable form, at the Company's 
discretion but subject to the reasonable approval of Subscribers) with the SEC, 
covering the resale of the Conversion Shares and Warrant Shares issuable to all 
Subscribers in this Offering. The Company shall, within ten ( 10) days of the 
filing of the Registration Statement, send a copy of the Registration Statement 
to Subscribers. Such Registration Statement shall initially cover a number of 
Conversion Shares and Warrant Shares equal to at least one million five hundred 
thousand (1,500,000) shares of Common Stock, allocated and reserved pro rata 
among the Subscribers, and shall cover, to the extent allowable by applicable 
law, such additional indeterminate number of shares of Common Stock as are 
required to effect the full conversion of the Preferred Stock, including the 
Preferred Stock issued upon exercise of the Preferred Warrants, and the full 
exercise of the Conversion Warrants, due to fluctuations in the price of the 
Company's Common Stock. The Company shall use its best efforts to have the 
Registration Statement declared effective as soon as possible. In the event that
the Company determines or is notified by a Holder that the Registration 
Statement does not cover a 

                                        11
<PAGE>
    
sufficient number of shares of Common Stock to effect conversion of all 
outstanding Preferred Stock then eligible for conversion, including the 
Preferred Stock issued upon the exercise of the Preferred Warrants, and exercise
of the outstanding Conversion Warrants, the Company shall, within five (5) 
business days, amend the Registration Statement or file a new registration 
statement to add such number of additional shares as would be necessary to 
effect all such conversions of the Preferred Stock and exercises of the 
Conversion Warrants. The rights of the holders of Common Stock and Warrant 
Shares to have their securities registered under the Registration Statement 
are set forth in the Registration Rights Agreement. If the Registration 
Statement is not declared effective within five (5) calendar months after the 
Last Closing or if any new or amended registration statement required to be 
filed hereunder is not declared effective within two (2) calendar months of
the date it is required to be filed, the Company shall pay Subscribers an amount
equal to two percent (2%) per month of the aggregate amount of Preferred Stock 
sold to Subscriber in the Offering, compounded monthly and accruing daily until 
the Registration Statement or a registration statement filed pursuant to Section
2 or Section 3 of the Registration Rights Agreement is declared effective (the 
"Late Registration Payment"), payable, at each Subscriber's option, in either 
cash or Common Stock. If Subscriber elects to be paid in cash, such Late 
Registration Payments shall be paid to such Subscriber within five (5) business 
days following the end of the month in which such Late Registration Payment was 
accrued. If Subscriber elects to be paid in Common Stock, such number of shares 
of Common Stock shall be determined as follows:
    
     Upon conversion of each share of Preferred Stock, the Company shall issue 
     to Subscriber the number of shares of Common Stock determined as set forth 
     in Section 5(a) of the Certificate of Designation plus an additional number
     of shares of Common Stock (the "Additional Shares") determined as set forth
     below:
    
               Additional Shares = Late Registration Payment
                                   -------------------------
                                        Conversion Price
    
where, "Conversion Price" has the definition ascribed to it in the 
Certificate of Designation. 
    
    Such Additional Shares shall also be deemed "Registrable Securities" as 
defined in the Registration Rights Agreement. The Company covenants to use its 
best efforts to remain eligible to use form S-1 for the registration required by
this Section 5.1 during all applicable times contemplated by this Agreement.
    
         5.6  CAPITAL RAISING LIMITATIONS; RIGHTS OF FIRST REFUSAL.
   
             5.6.1 CAPITAL RAISING LIMITATIONS. For a period of one hundred 
eighty (180) days following the date of Last Closing, the Company shall not 
issue or agree to issue, except (i) as contemplated hereunder, (ii) pursuant to 
an offering or offerings which, combined with this Offering, do not, in the 
aggregate, exceed five million dollars ($5,000,000 U.S.), as further limited 
below (a "Limited Offering"), (iii) pursuant to any employee stock purchase plan
or employee stock option plan of the Company in effect on June 10, 1997, and 
disclosed in the Disclosure Documents, or (iv) pursuant to any security, option,
warrant, scrip, call or commitment or right disclosed in the Capitalization 
Schedule, any equity securities of the Company (or any security convertible into
or exercisable or exchangeable, directly or indirectly, for equity securities of
the Company) if such securities are issued at a price (or in the case of 
securities which are convertible into or exercisable or exchangeable, directly 
or indirectly, for Common Stock, if such securities are convertible, exercisable
or exchangeable, as appropriate, at a conversion price, exercise price or 
exchange price) less than the current market price for Common Stock on the date 
of issuance (in the case of Common Stock) or the conversion, exercise or 
exchange date (in the case of securities convertible into or exercisable or 
exchangeable, directly or indirectly, for Common Stock). In addition, during 
such period, the Company shall not issue, or agree to issue, any debt securities
which are issued at a discount to the principal amount thereof. Notwithstanding

                                   12
<PAGE>

the above, a Limited Offering is further limited as follows: the terms of the 
securities in a Limited Offering must be on the same or substantially similar 
terms as the Series A Preferred Stock being issued in this Offering; including 
but not limited to the requirement that the securities in a Limited Offering (a)
shall not be convertible into Common Stock at a discount of less than 85% of the
market price and (b) shall not be convertible into Common Stock prior to the 
date that is six (6) months after the Last Closing of this Offering.
    
            5.6.2  RIGHT OF FIRST OFFER. The Company agrees that, during the 
period beginning on the date hereof and terminating on the first anniversary 
of the date of the Last Closing, the Company will not, without the prior written
consent of each Subscriber (which shall be deemed given for the warrants to 
purchase Common Stock issued or to be issued to the Placement Agent in 
consideration of its services in connection with this Agreement and the 
transactions contemplated hereby) issue or sell, or agree to issue or sell any 
equity or debt securities of the Company or any of its subsidiaries (or any 
security convertible into or exercisable or exchangeable, directly or 
indirectly, for equity or debt securities of the Company or any of its 
subsidiaries) ("Future Offerings") unless the Company shall have first delivered
to each Subscriber at least thirty (30) business days prior to the closing of
such Future Offering, written notice describing the proposed Future Offering, 
including the terms and conditions thereof, and providing each Subscriber and 
its affiliates an option during the twenty (20) business day period following 
delivery of such notice to purchase up to the full amount of the securities 
being offered in the Future Offering on the same terms as contemplated by such 
Future Offering (the limitations referred to in this sentence are collectively 
referred to as the "Capital Raising Limitations").  Notwithstanding the 
foregoing, if the Subscriber chooses not to participate in any Future Offerings,
then any debt or equity security issued as a result of the Future Offerings
which, combined with this Offering, in the aggregate, exceed five million 
dollars ($5,000,00.0 U.S.), will be ineligible for sale and/or conversion, as 
the case may be, until the date which is twelve (12) months after the Last 
Closing. The Capital Raising Limitations shall not apply to any transaction
involving issuances of securities in connection with a merger, consolidation, 
acquisition or sale of assets, or in connection with any strategic partnership 
or joint venture (the primary purpose of which is not to raise equity capital), 
or in connection with the disposition or acquisition of a business, product or 
license by the Company or exercise of options by employees, consultants or 
directors. The Capital Raising Limitations also shall not apply to (a) the 
issuance of securities pursuant to an underwritten public offering, (b) the 
issuance of securities upon exercise or conversion of the Company's options, 
warrants or other convertible securities outstanding as of the date hereof or 
(c) the grant of additional options or warrants, or the issuance of additional 
securities, under any Company stock option or restricted stock plan for the 
benefit of the Company's employees, directors or consultants.
    
         5.7  FINANCIAL 10-K STATEMENTS, ETC. AND CURRENT REPORTS ON FORM 8-K. 
The Company shall provide Subscriber with copies of its annual reports on Form 
10-K, quarterly reports on Form 10-Q and current reports on form 8-K for as long
as the Preferred Stock may remain outstanding.
    
         5.8  OPINION OF COUNSEL. Subscribers shall, upon purchase of the 
Preferred Stock and accompanying Warrants pursuant to this Agreement, receive 
an opinion letter from Gary R. Blume, P.C. ("Counsel"), counsel to the Company, 
to the effect that (i) the Company is duly incorporated and validly existing; 
(ii) this Agreement, the issuance of the Preferred Stock at Closing, the 
issuance of the Conversion Warrants, the issuance of the Preferred Warrants, the
issuance of the Conversion Shares upon conversion of the Preferred Stock, the 
issuance of the Warrant Shares upon exercise of the Conversion Warrants and the 
issuance of the Preferred Stock Rights Agreement, the irrevocable Instructions 
to Transfer Agent and the Escrow Agreement are 

                                   13
<PAGE>

valid and binding obligations of the Company, enforceable in accordance with 
their terms, except as enforceability of the indemnification provisions may be 
limited by principles of public policy, and subject to laws of general 
application relating to bankruptcy, insolvency and the relief of debtors and
rules of laws governing specific performance and other equitable remedies; and 
(iv) based upon the representations and acknowledgments of Subscribers contained
in Sections 2 and 3 hereof, the Preferred Stock, the Conversion Warrants and the
Preferred Warrants have been, and the Conversion Shares, the Warrant Shares, and
the Preferred Stock issued upon exercise of the Preferred Warrants will be, 
issued in a transaction that is exempt from the registration requirements of the
Act and applicable state securities laws; and (v) the Conversion Shares are 
authorized for listing on the OTC Bulletin Board subject to notice of issuance.
    
         5.9  REMOVAL OF LEGEND UPON CONVERSION. As contemplated by the 
Certificate of Designation, upon conversion of the Preferred Stock, Subscriber 
shall submit a Notice of Conversion and Resale, substantially in the form 
attached hereto as Exhibit N. The Legend shall be removed and the Company shall 
issue a certificate without such Legend to the holder of any Security upon which
it is stamped, and a certificate for a security shall be originally issued 
without the Legend, if, unless otherwise required by state securities laws, (a) 
the sale of such Security is registered under the Act, or (b) such holder 
provides the Company with an opinion of counsel, in form, substance and scope
customary for opinions of counsel in comparable transactions (the reasonable 
cost of which shall be home by the Company), to the effect that a public sale 
or transfer of such Security may be made without registration under the Act, or 
(c) such holder provides the Company with reasonable assurances that such 
Security can be sold pursuant to Rule 144. Each Subscriber agrees to sell all
Securities, including those represented by a certificate(s) from which the 
Legend has been removed, or which were originally issued without the Legend, 
pursuant to an effective registration statement and to deliver a prospectus in 
connection with such sale or in compliance with an exemption from the 
registration requirements of the Act. In the event the Legend is removed from 
any Security or any Security is issued without the Legend and thereafter the 
effectiveness of a registration statement covering the resale of such Security 
is suspended or the Company determines that a supplement or amendment thereto is
required by applicable securities laws, then upon reasonable advance notice to
Subscriber holding such Security, the Company may require that the Legend be 
placed on any such Security that cannot then be sold pursuant to an effective 
registration statement or Rule 144 or with respect to which the opinion referred
to in clause (b) next above has not been rendered, which Legend shall be removed
when such Security may be sold pursuant to an effective registration statement 
or Rule 144 or such holder provides the opinion with respect thereto described 
in clause (b) next above.
    
         5.10  LISTING. Subject to the remainder of this Section 5.10, the 
Company shall ensure that its shares of Common Stock (including all Conversion 
Shares and Warrant Shares) are listed and available for trading on the OTC 
Bulletin Board. The Company shall promptly following the Last Closing use its 
best efforts to satisfy the listing requirements of, and secure the listing of 
the Common Stock (including, without limitation, the Conversion Shares and 
Warrant Shares) upon, the Nasdaq SmallCap Market ("NASDAQ"). Thereafter, the 
Company shall (i) use its best efforts to continue the listing and trading of 
its Common Stock on the NASDAQ, or on the Nasdaq National Market System ("NMS"),
the New York Stock Exchange ("NYSE") or the American Stock Exchange ("AMEX"); 
(ii) take all action necessary to cause and maintain the listing and trading of
its Common Stock on the OTC Bulletin Board at any time the Common Stock is not 
listed and traded on NASDAQ, NMS, NYSE or AMEX; and (iii) comply in all respects
with the Company's reporting, filing and other obligations under the by-laws or 
rules of the National Association of Securities Dealers ("NASD") and such 
exchanges, as applicable.
    
         5.11  THE COMPANY'S INSTRUCTIONS TO TRANSFER AGENT. The Company will 
issue to its Transfer Agent the Irrevocable Instructions to Transfer Agent 
substantially in the form of Exhibit H instructing the Transfer Agent to issue 
certificates, registered in the name of each Subscriber or its nominee, for the 
Conversion Shares and Warrant Shares in such amounts as  
    
                               14
<PAGE>

specified from time to time by such Subscriber to the Company upon conversion of
the Preferred Stock. Such certificates shall bear a Legend only to the extent 
permitted by Section 5.9 hereof. The Company warrants that no instruction, 
other than such instructions referred to in Section 5.9 hereof or in this 
Section 5.11 and stop transfer instructions to give effect to Section 3.7 hereof
in the case of Conversion Shares and Warrant Shares prior to registration of the
Conversion Shares and Warrant Shares under the Act, will be given by the Company
to its transfer agent and that the Securities shall otherwise be freely 
transferable on the books and records of the Company as and to the extent
provided in this Agreement and the Registration Rights Agreement. Nothing in 
this Section shall affect in any way each Subscriber's obligations and 
agreement set forth in Section 5.10 hereof to resell the Securities pursuant to 
an effective registration statement and to deliver a prospectus in connection 
with such sale or in compliance with an exemption from the registration 
requirements of applicable securities laws. If (a) a Subscriber provides the 
Company with an opinion of counsel, which opinion of counsel shall be in form, 
substance and scope customary for opinions of counsel in comparable transactions
(the reasonable cost of which shall be borne by the Company), to the effect that
the Securities to be sold or transferred may be sold or transferred pursuant to 
an exemption from registration or (b) a Subscriber transfers Securities to an 
affiliate which is an accredited investor pursuant to Rule 144, the Company 
shall permit the transfer, and, in the case of Conversion Shares and Warrant 
Shares, promptly instruct its transfer agent to issue one or more certificates 
in such name and in such denomination as specified by such Subscriber. The 
Company acknowledges that a breach by it of its obligations hereunder will cause
irreparable harm to a Subscriber by vitiating the intent and purpose of the 
transaction contemplated hereby. Accordingly, the Company acknowledges that the 
remedy at law for a breach of its obligations under this Section 5.1 I will be 
inadequate and agrees, in the event of a breach or threatened breach by the 
Company of the provisions of this Section 5.1 1, that a Subscriber shall be 
entitled, in addition to all other available remedies, to an injunction 
restraining any breach and requiring immediate issuance and transfer, without 
the necessity of showing economic loss and without any bond or other security
being required. The Company hereby agrees that it will not unilaterally 
terminate its relationship with the Transfer Agent for any reason prior to the 
date which is three (3) years after the Last Closing or one (1) month after the 
first date that no Preferred Stock and no Warrants are outstanding, whichever is
earlier (the "Ending Date"). In the event the Company's agency relationship with
the Transfer Agent should be terminated for any other reason prior to the date 
which is three (3) years after the Last Closing, the Company's Transfer Agent 
shall continue acting as transfer agent pursuant to the terms of the Irrevocable
Instructions to Transfer Agent until such time that a successor transfer agent 
(i) is appointed by the Company; (ii) is approved by seventy-five percent (75%) 
of the Subscribers of outstanding Preferred Stock; and (iii) executes and agrees
to be bound by the terms of the Irrevocable instructions to Transfer Agent. 
    
    6.  SUBSCRIBER COVENANT/MISCELLANEOUS
    
         6.1  REPRESENTATIONS AND WARRANTIES SURVIVE THE CLOSING; SEVERABILITY.
Subscriber's and the Company's representations and warranties shall survive the 
Closing of the transactions contemplated by this Agreement notwithstanding any 
due diligence investigation made by or on behalf of the party seeking to rely 
thereon. In the event that any provision of this Agreement becomes or is 
declared by a court of competent jurisdiction to be illegal, unenforceable or 
void, this Agreement shall continue in full force and effect without said 
provision; provided that no such severability shall be effective if it 
materially changes the economic benefit of this Agreement to any party.
    
         6.2  SUCCESSORS AND ASSIGNS. The terms and conditions of this Agreement
shall inure to the benefit of and be binding upon the respective successors and 
assigns of the parties. Nothing in this Agreement, express or implied, is 
intended to confer upon any party other than the parties hereto or their 
respective successors and assigns any rights, remedies, obligations, or 
liabilities under or by reason of this Agreement, except as expressly provided 
in this Agreement. Subscriber may assign Subscriber's rights hereunder, in 
connection with any private sale of the 
    
                                     15
<PAGE>
    
Preferred Stock of such Subscriber, so long as, as a condition precedent to such
transfer, the transferee executes an acknowledgment agreeing to be bound by the 
applicable provisions of this Agreement.
    
        6.3  GOVERNING LAW. This Agreement shall be governed by and construed 
under the laws of the State of Delaware without respect to conflict of laws.
    
        6.4  EXECUTION IN COUNTERPARTS PERMITTED. This Agreement may be executed
in any number of counterparts, each of which shall be enforceable against the 
parties actually executing such counterparts, and all of which together shall 
constitute one (1) instrument.  
    
        6.5  TITLES AND SUBTITLES; GENDER. The titles and subtitles used in this
Agreement are used for convenience only and are not to be considered in 
construing or interpreting this Agreement. The use in this Agreement of a 
masculine, feminine or neither pronoun shall be deemed to include a reference to
the others.
    
        6.6  WRITTEN NOTICES, ETC. Any notice, demand or request required or 
permitted to be given by the Company or Subscriber pursuant to the terms of 
this Agreement shall be in writing and shall be deemed given when delivered 
personally, or by facsimile (with a hard copy to follow by two (2) day courier),
addressed to the parties at the addresses and/or facsimile telephone number of 
the parties set forth at the end of this Agreement or such other address as a 
party may request by notifying the other in writing.
    
         6.7  EXPENSES. Each of the Company and Subscriber shall pay all costs 
and expenses that it respectively incurs, with respect to the negotiation, 
execution, delivery and performance of this Agreement. 
    
         6.8  ENTIRE AGREEMENT; WRITTEN AMENDMENTS REQUIRED.  This Agreement, 
the Certificate of Designation, the Preferred Stock certificates, the Conversion
Warrants, the Preferred Warrants, the Registration Rights Agreement, the Escrow 
Agreement, the Irrevocable Instructions to Transfer Agent and the other 
documents delivered pursuant hereto constitute the full and entire understanding
and agreement between the parties with regard to the subjects hereof and 
thereof, and no party shall be liable or bound to any other party in any manner 
by any warranties, representations or covenants except as specifically set forth
herein or therein. Except as expressly provided herein, neither this Agreement 
nor any term hereof may be amended, waived, discharged or terminated other than
by a written instrument signed by the party against whom enforcement of any such
amendment, waiver, discharge or termination is sought.
    
         6.9  ARBITRATION. Any controversy or claim arising out of or related to
this Agreement or the breach thereof, shall be settled by binding arbitration in
Delaware in accordance with the Expedited Procedures (Rules 53-57) of the 
Commercial Arbitration Rules of the American Arbitration Association ("AAA"). 
A proceeding shall be commenced upon written demand by Company or any Subscriber
to the other. The arbitrator(s) shall enter a judgment by default against any 
party which fails or refuses to appear in any properly noticed arbitration 
proceeding. The proceeding shall be conducted by one (1) arbitrator, unless the 
amount alleged to be in dispute exceeds two hundred fifty thousand dollars 
($250,000), in which case three (3) arbitrators shall preside. The arbitrator(s)
will be chosen by the parties from a list provided by the AAA, and if they are 
unable to agree within ten (10) days, the AAA shall select the arbitrator(s). 
The arbitrators must be experts in securities law and financial transactions. 
The arbitrators shall assess costs and expenses of the arbitration, including
all attorneys' and experts' fees, as the arbitrators believe is appropriate in 
light of the merits of the parties' respective positions in the issues in 
dispute. Each party submits irrevocably to the jurisdiction of any state court 
sitting in Wilmington, Delaware or to the United States District Court sitting 
in Delaware for purposes of enforcement of any discovery order, judgment or 
award in connection with such arbitration. The award of the arbitrator(s) shall

                                   16
<PAGE>
    
be final and binding upon the parties and may be enforced in any court having 
jurisdiction. The arbitration shall be held in such place as set by the 
arbitrator(s) in accordance with Rule 55. 
    
    7.  SUBSCRIPTION AND WIRING INSTRUCTIONS; IRREVOCABILITY.
    
         7.1  SUBSCRIPTION
    
         (a)  WIRE TRANSFER OF SUBSCRIPTION FUNDS. Subscriber shall send this 
              signed Agreement by facsimile to the Placement Agent at 
              (770) 640-7150, and send the subscription funds by wire transfer, 
              to the Escrow Agent as follows:
    
              First Union National Bank
              ABA No. 053000219
              Account No. 465946fTrust Ledger
              ATTN: Claire Moore
              Reference:
              Acct Name: MedcaretSwartz Investments, LLC
              Ref: Subscriber's Name
              Account No. 3072236164
              Contact: Nicole Stefaruni
              Telephone No.: (404) 827-7326
    
              SWIFT Code: FUNBUS33
    
        (b)  IRREVOCABLE SUBSCRIPTION. Subscriber hereby acknowledges and 
             agrees, subject to the provisions of any applicable laws providing 
             for the refund of subscription amounts submitted by Subscriber, 
             that this Agreement is irrevocable and that Subscriber is not 
             entitled to cancel, terminate or revoke this Agreement or any other
             agreements executed by such Subscriber and delivered pursuant 
             hereto, and that this Agreement and such other agreements shall 
             survive the death or disability of such Subscriber and shall be 
             binding upon and inure to the benefit of the parties and their 
             heirs, executors, administrators, successors, legal representatives
             and assigns. If the Securities subscribed for are to be owned by 
             more than one person, the obligations of all such owners under
             this Agreement shall be joint and several, and the agreements, 
             representations, warranties and acknowledgments herein contained 
             shall be deemed to be made by and be binding upon each such person
             and his heirs, executors, administrators, successors, legal 
             representatives and assigns. Notwithstanding the foregoing, (i) if 
             the conditions to Closing are not satisfied or (ii) if the 
             Disclosure Documents are discovered prior to Closing to contain 
             statements which are materially inaccurate, or omit statements of 
             material fact, Subscriber may revoke or cancel this Agreement.
    
        (c)  COMPANY'S RIGHT TO REJECT SUBSCRIPTION. Subscriber understands that
             this Agreement is not binding on the Company until the Company 
             accepts it. This Agreement shall be accepted by the Company when 
             the Company countersigns this Agreement. Subscriber hereby confirms
             that the Company has full right in its sole discretion to accept or
             reject the subscription of Subscriber, in whole or in part, 
             provided that, if the Company decides to reject such subscription,
             the Company must do so promptly and in writing.  In the case of 
             rejection, the Company will promptly return any rejected payments 
             and (if rejected in whole) copies of all executed subscription
    
                                 17
<PAGE>
             documents without limitation this Agreement) to Subscriber (with 
             any earned interest).   
    
        7.2  ACCEPTANCE OF SUBSCRIPTION.  In the case of acceptance of 
Subscriber's subscription, ownership of the number of securities being purchased
hereby will pass to Subscriber upon the Closing.

        7.3  SUBSCRIBER TO FORWARD ORIGINAL SIGNED SUBSCRIPTION AGREEMENT TO
COMPANY.  Subscriber agrees to courier to Company his, her or its original inked
signed Subscription Agreement within two (2) days after faxing said signed 
agreement to Placement Agent.
    
    8.  INDEMNIFICATION.
    
    The Company agrees to indemnify and hold harmless Subscriber and the 
Placement Agent and each of their officers, directors, employees and agents, and
each person who controls Subscriber or the Placement Agent within the meaning of
the Act or the Exchange Act (each, a "Subscriber Indemnified Party") against any
losses, claims, damages or liabilities, joint or several, to which it, they or 
any of them, may become subject and not otherwise reimbursed arising from or due
to any untrue statement of a material fact or the omission to state any material
fact required to be stated in order to make the statements not misleading in any
representation or warranty made by the Company contained in this Agreement or in
any statements contained in the Disclosure Documents.
    
    Subscriber agrees to indemnify and hold harmless Company and the Placement 
Agent and each of their officers, directors, employees and agents, and each 
person who controls Company or the Placement Agent within the meaning of the 
Act or the Exchange Act (each, a "Company Indemnified Party") (a Subscriber 
Indemnified Party or a Company Indemnified Party may be hereinafter referred 
to singularly as "Indemnified Party") against any losses, claims, damages or 
liabilities, joint or several, to which it, they or any of them, may become 
subject and not otherwise reimbursed arising from or due to any untrue statement
of a material fact or the omission to state any material fact required to be 
stated in order to make the statements not misleading in any representation or
warranty made by Subscriber contained in this Agreement.
    
    Promptly after receipt by an Indemnified Party of notice of the commencement
of any action pursuant to which indemnification may be sought, such Indemnified 
Party will, if a claim in respect thereof is to be made against the other party 
(hereinafter "Indemnitor") under this Section 8, deliver to the Indemnitor a 
written notice of the commencement thereof and the Indemnitor shall have the
right to participate in and to assume the defense thereof with counsel 
reasonably selected by the Indemnitor, provided, however, that an Indemnified 
Party shall have the right to retain its own counsel, with the reasonably 
incurred fees and expenses of such counsel to be paid by the Indemnitor, if 
representation of such Indemnified Party by the counsel retained by the 
Indemnitor would be inappropriate due to actual or potential conflicts of 
interest between such Indemnified Party and any other party represented by such 
counsel in such proceeding. The failure to deliver written notice to the 
Indemnitor within a reasonable time of the corornencement of any such action,
if prejudicial to the Indemnitor's ability to defend such action, shall relieve 
the Indemnitor of any liability to the Indemnified Party under this Section 8, 
but the omission to so deliver written notice to the Indemnitor will not relieve
it of any liability that it may have to any Indemnified Party other than under 
this Section 8 to the extent it is prejudicial. 
    
                                 18
<PAGE>
    
     9.  CERTAIN ADDITIONAL LEGENDS AND INFORMATION.
    
FOR FLORIDA RESIDENTS:
    
    THE SECURITIES REFERRED TO HEREIN WILL BE SOLD TO, AND ACQUIRED BY, THE 
HOLDER IN A TRANSACTION EXEMPT UNDER SECTION 517.061 OF THE FLORIDA SECURITIES 
ACT. THE SECURITIES HAVE NOT BEEN REGISTERED UNDER SAID ACT IN THE STATE OF 
FLORIDA. IN ADDITION, ALL FLORIDA RESIDENTS SHALL HAVE THE PRIVILEGE OF VOIDING 
THE PURCHASE WITHIN THREE (3) DAYS AFTER THE FIRST TENDER OF CONSIDERATION IS 
MADE BY SUCH SUBSCRIBER TO THE ISSUER, AN AGENT OF THE ISSUER, OR AN ESCROW 
AGENT OR WITHIN THREE DAYS AFTER THE AVAILABILITY OF THAT PRIVILEGE IS 
COMMUNICATED TO SUCH SUBSCRIBER, WHICHEVER OCCURS LATER.
    
FOR MAINE RESIDENTS:
    
    THESE SECURITIES ARE BEING SOLD PURSUANT TO AN EXEMPTION FROM REGISTRATION 
WITH THE BANK SUPERINTENDENT OF THE STATE OF MAINE UNDER SECTION 10502(2)(R) OF 
TITLE 32 OF THE MAINE REVISED STATUTES. THESE SECURITIES MAY BE DEEMED 
RESTRICTED SECURITIES AND AS SUCH THE HOLDER MAY NOT BE ABLE TO RESELL THE 
SECURITIES UNLESS PURSUANT TO REGISTRATION UNDER STATE OR FEDERAL SECURITIES 
LAWS OR UNLESS AN EXEMPTION UNDER SUCH LAWS EXISTS.
    
FOR PENNSYLVANIA RESIDENTS:
    
    EACH PENNSYLVANIA RESIDENT WHO SUBSCRIBES FOR THE SECURES BEING OFFERED 
HEREBY AGREES NOT TO SELL THESE SECURITIES FOR A PERIOD OF TWELVE MONTHS AFTER 
THE DATE OF PURCHASE UNLESS SUCH SECURITIES HAVE BEEN REGISTERED FOR SALE. UNDER
PROVISION OF THE PENNSYLVANIA SECURITIES ACT OF 1972 (THE "1972 ACT'), EACH 
PENNSYLVANIA RESIDENT SHALL HAVE THE RIGHT TO WITHDRAW HIS ACCEPTANCE WITHOUT 
INCURRING ANY LIABILITY, TO THE SELLER, UNDERWRITER (IF ANY) OR ANY PERSON, 
WITHIN TWO (2) BUSINESS DAYS FROM THE DATE OF RECEIPT BY THE ISSUER OF HIS 
WRITTEN BINDING CONTRACT OF PURCHASE OR IN THE CASE OF A TRANSACTION IN WHICH
THERE IS NO WRITTEN BINDING CONTRACT OF PURCHASE, WITHIN TWO BUSINESS DAYS AFTER
HE MAKES THE INITIAL PAYMENT FOR THE SECURITIES BEING OFFERED. TO ACCOMPLISH 
THIS WITHDRAWAL, A SUBSCRIBER NEED ONLY SEND A LETTER OR TELEGRAM TO THE SELLING
AGENT AT THE ADDRESS SET FORTH IN THE TEXT OF THE MEMORANDUM, INDICATING HIS OR 
HER INTENTION TO WITHDRAW. SUCH LETTER OR TELEGRAM SHOULD BE SENT AND POSTMARKED
PRIOR TO THE END OF THE AFOREMENTIONED SECOND BUSINESS DAY. IT IS PRUDENT TO 
SEND SUCH LETTER BY CERTIFIED MAIL, RETURN RECEIPT REQUESTED, TO ENSURE THAT IT 
IS RECEIVED AND ALSO TO EVIDENCE THE TIME WHEN IT WAS MAILED. IF THE REQUEST IS 
MADE ORALLY (IN PERSON OR BY TELEPHONE, TO THE SELLING AGENT AT THE NUMBER 
LISTED IN THE TEXT OF THE MEMORANDUM) A WRITTEN CONFIRMATION THAT THE REQUEST 
HAS BEEN RECEIVED SHOULD BE REQUESTED.
    
FOR NEW HAMPSHIRE RESIDENTS:
    
    NEITHER THE FACT THAT A REGISTRATION STATEMENT OR AN APPLICATION FOR A 
LICENSE HAS BEEN FILED WITH THE STATE OF NEW HAMPSHIRE NOR THE FACT THAT A 
SECURITY IS EFFECTIVELY REGISTERED OR A PERSON IS LICENSED IN THE STATE OF NEW 
HAMPSHIRE CONSTITUTES A FINDING BY THE SECRETARY OF STATE THAT ANY DOCUMENT 
FILED UNDER RSA 421-B IS TRUE, COMPLETE AND NOT MISLEADING. NEITHER ANY SUCH 
FACT NOR THE FACT THAT AN EXEMPTION OR EXCEPTION IS AVAILABLE FOR A SECURITY OR 
A TRANSACTION     
              
                                   l9
<PAGE>

MEANS THAT THE SECRETARY OF STATE HAS PASSED IN ANY WAY UPON TO MERITS OR 
QUALIFICATIONS OF, OR RECOMMENDED OR GIVEN APPROVAL TO, ANY PERSON, SECURITY, OR
TRANSACTION. IT IS UNLAWFUL TO MAKE, OR CAUSE TO BE MADE, TO ANY PROSPECTIVE 
PURCHASER, CUSTOMER OR CLIENT ANY REPRESENTATION INCONSISTENT WITH THE 
PROVISIONS OF THIS PARAGRAPH.
    


                        [INTENTIONALLY LEFT BLANK]
    
                                  20
<PAGE>
    
    10.  NUMBER OF SHARES AND PURCHASE PRICE. Subscriber subscribes for shares 
of Preferred Stock (in the amount of $10,000 per Share) and the accompanying 
Conversion Warrants and Preferred Warrants against payment by wire transfer in 
the amount of $__________ ("Purchase Price").
    
    11.  ACCREDITED INVESTOR. Subscriber is (check applicable box):
    
    (a)  [ ] a corporation, business trust, or partnership not formed for the 
             specific purpose of acquiring the securities offered, with total 
             assets in excess of $5,000,000.

    (b)  [ ] any trust, with total assets in excess of $5,000,000, not formed 
             for the specific purpose of acquiring the securities offered, whose
             purchase is directed by a sophisticated person who has such 
             knowledge and experience in financial and business matters that he 
             is capable of evaluating the merits and risks of the prospective 
             investment.

    (c)  [ ] an individual, who 

         [ ] is a director, executive officer or general partner of the issuer 
             of the securities being offered or sold or a director, executive 
             officer or general partner of a general partner of that issuer.

         [ ] has an individual net worth, or joint net worth with that person's 
             spouse, at the time of his purchase exceeding $1,000,000.

         [ ] had an individual income in excess of $200,000 in each of the two 
             most recent years or joint income with that person's spouse in 
             excess of $300,000 in each of those years and has a reasonable 
             expectation of reaching the same income level in the current year.

    (d)  [ ] an entity each equity owner of which is an entity described in a-b 
             above or is an individual who could check one (1) of the last three
             (3) boxes under subparagraph (c) above.
    
    (e)  [ ] other [specify] __________________________________________
    
    The undersigned acknowledges that this Agreement and the subscription 
represented hereby shall not be effective unless accepted by the Company as 
indicated below.
    
    IN WITNESS WHEREOF, the undersigned Subscriber does represent and certify 
under penalty of perjury that the foregoing statements are true and correct and 
that Subscriber by the following signature(s) executed this Agreement.
    
    Dated this ______ day of ______________________, 1997.
    

__________________        _________________________
Your Signature            PRINT EXACT NAME IN WHICH YOU WANT


__________________        DELIVERY INSTRUCTIONS:
Name: Please Print        Please type or print address where your security is 
                          to be delivered

__________________        ATTN.:___________________
Title/Representative 
Capacity (if applicable)
    
___________________       ___________________________
Name of Company You       Street Address
Represent (if applicable) 
    
___________________       ____________________________
Place of Execution of     City, State or Province, Country, Offshore Postal Code
this Agreement         
     
                          ____________________________
                          Phone Number (For Federal Express) and 
                          Fax Number (re: Notice)

        THIS AGREEMENT IS ACCEPTED BY THE COMPANY IN THE AMOUNT OF $____ ON
THE ____ DAY OF June, 1997.
    
    Medcare Technologies, Inc.
    By: ___________________
    Name: _________________
    Title: __________________

<PAGE>

                             MEDCARE TECHNOLOGIES, INC.
    
                                SIGNIFICANT RISKS
    
LIMITED OPERATING HISTORY; HISTORY OF LOSSES
    
Since inception, MedCare Technologies has primarily been engaged in the research
and development of its treatment program for bladder and bowel incontinence. 
While there is ample evidence that significant demand exists for a treatment 
program such as MedCare's, there is no guarantee that MedCare will be successful
in achieving its operation goals or successful in gaining wide acceptance among 
physicians or sufferers.  As a result, the Company may continue to suffer losses
from operations in the future.
    
RELIANCE ON SKILLED AND KEY PERSONNEL
    
    As a part of its expansion plans, the company plans to expend substantial 
funds for recruiting and training highly skilled personnel, purchasing medical 
equipment and for advertising and marketing. There can be no assurances that 
these highly skilled individuals, such as registered nurses or nurse 
practitioners, will be readily available and slower than anticipated sales 
growth may adversely affect the company's ability to continue funding its 
expansion program. The Company is also dependent upon a number of key management
personnel. The loss of the services of one or more key individuals would have a 
material adverse effect on the Company. The Company's success will also
depend on its ability to attract and retain other highly qualified scientific 
and management personnel. The company faces competition for such personnel and 
there can be no assurance that the company will be able to attract or retain 
such personnel.
    
PROTECTION OF PROPRIETARY TREATMENT PROGRAM
    
    The Company's ability to compete and expand effectively will depend, in 
part, on its ability to develop and maintain proprietary aspects of its 
treatment program for bladder and bowel incontinence. The Company relies on an 
unpatented proprietary treatment protocol and there can be no assurances that 
others will not independently develop substantially equivalent or superseding
proprietary protocols, or that an equivalent program will not be marketed in 
competition with the company's program, thereby substantially reducing the value
of the Company's proprietary treatment program. There can be no assurance that 
any confidentiality agreements between the company and its employees will 
provide meaningful protection for the Company's trade secrets, know-how or
other proprietary information in the event of any unauthorized use or disclosure
of such trade secrets, know-how or other proprietary information. 
    
UNCERTAINTY RELATING TO THIRD-PARTY REIMBURSEMENT
    
    In the United States and in certain foreign countries, third-party 
reimbursement is currently generally available for certain procedures, such as 
surgery and biofeedback training by EMG application and generally unavailable 
for patient management products such as diapers, pads, and urethral plugs. While
the Company's treatment program is currently covered by the third party payers, 
there can be no assurances that such coverage will remain in effect in the 
future.
    
                                    EXHIBIT I
                                        
<PAGE>

                             MEDCARE TECHNOLOGIES, INC.
    
                                CAPITALIZATION TABLE
    
100,000,000 common shares authorized with $0.001 par value As at March 31, 1997,
there were 6,445,185 issued and outstanding 

1,000,000 Preferred shares authorized with $0.25 par value - between 200 and 300
shares of which are expected to be issued in conjunction with this Offering.
    
    Current Outstanding Options:
    
    434,500         Exercisable at $3.00 until December 31, 2001
    292,000         Exercisable at $4.50 until June 20, 2001
    500,000*        200,000 set aside at $4.50 until November 18th, 2001
    
    *Subject to shareholder approval at AGM on June 17, 1997
    
                                EXHIBIT J
<PAGE>


                          MEDCARE TECHNOLOGIES, INC.
    
                           USE OF PROCEEDS STATEMENT
    
The net proceeds to the Company from the sale of the stock offered hereby are 
estimated to be $1,850,000 if the principal amount of $2,000,000 of Preferred 
Stock is placed and $2,775,000 if the principal amount of $3,000,000 of 
Preferred Stock is placed, after deductng estimated offering expenses payable by
the Company.
    
<TABLE>
<CAPTION>
                                   Net Proceeds             Net Proceeds
Application of Proceeds            of $1,850,000            of $2,775,000
-----------------------------      -----------------        -----------------
<S>                                <C>                      <C>
MedCare Program Expansion          $l,250,000               $1,250,000
Public (Financial) Relations       $250,000                 $250,000
Working Capital                    $350,000                 $1,275,000
    
                                   EXHIBIT K
<PAGE>

                       MEDCARE TECHNOLOGIES, INC.
    
              PATENTS, TRADEMARKS, TRADENAMES, COPYRIGHTS,
        KNOW-HOW, TECHNOLOGY AND OTHER INTELLECTUAL PROPERTIES
    
United States Trademark Application:
    
                   Medcare and design, filed April 21, 1997
    
Canadian Trademark Application:

                         Medcare and design, April 22, 1997
    


                                  Exhibit L-1
<PAGE>          

                          MEDCARE TECHNOLOGIES, INC.
    
    LICENSES AND OTHER RIGHTS GRANTED TO OTHERS TO USE PATENTS, TRADEMARKS, 
TRADENAMES, COPYRIGHTS, KNOW-HOW, TECHNOLOGY AND OTHER INTELLECTUAL PROPERTIES.


    
                                   -NONE-
    




                                   Exhibit L-2

<PAGE>
    
                           MEDCARE TECHNOLOGIES, INC.
    
    LINCENSES AND OTHER RIGHTS GRANTED TO MEDCARE TO USE PATENTS, TRADEMARKS, 
TRADENAMES, COPYRIGHTS, KNOW-HOW, TECHNOLOGY AND OTHER INTELLECTUAL PROPERTIES.


    
                                   -NONE-


                                 Exhibit L-3
<PAGE>    

                            MEDCARE TECHNOLOGIES, INC.
    
                           CAPACITIES OF KEY EMPLOYEES
    
HARMEL S. RAYAT - PRESIDENT, CHIEF EXECUTIVE OFFICER AND DIRECTOR
    
Primarily responsible for overall business strategy and expansion, negotiate all
contracts and agreements with physicians and medical management companies, 
billing matters and communicating with the financial community.
    
VALERIE BOELDT-UMBRIGHT - VICE PRESIDENT AND DIRECTOR OF CLINICAL SERVICES
    
Primarily responsible for developing medical protocols and the ongoing 
development of new medical protocols, teaching and training of clinical staff, 
ongoing supervision of clinical staff and all matters relating to the 
development of the MedCare Program. 
    
    
    
                                 EXHIBIT M
                                          
<PAGE>

                      NOTICE OF CONVERSION [AND RESALE]
    
                   (To be Executed by the Registered Holder
                   in order to Convent the Preferred Stock)
    
The undesigned hereby irrevocably elects to convert __________ shares of Series 
A Preferred Stock, represented by stock certificate No(s). ________ (the 
"Preferred Stock Certificates") into shares of common stock ("Common Stock") of 
Medcare Technologies, Inc. (the "Company") according to the conditions of the 
Certificate of Designation of Series A Preferred Stock, as of the date written 
below [in connection with the resale of the underlying Common Stock unless 
otherwise indicated below]. If shares are to be issued in the name of a person 
other than the undersigned, the undersigned will pay all transfer taxes payable 
with respect thereto and is delivering herewith such certificates. No fee will 
be charged to the Holder for any conversion, except for transfer taxes, if any.
A copy of each of the Preferred Stock Certificates being converted is attached 
hereto. The undersigned agrees to deliver a Prospectus in connection with any 
sale made pursuant to the Registration Statement, as provided in Section 5.10 of
the Subscription Agreement.
    
_____ Check here if this conversion is not being made in connection with the 
resale of the Common Stock.
    
                                          Date of Conversion: ________________
    
                                          Applicable Conversion Price: _______
    
                                          Number of Shares of
                                          Common Stock to be Issued: _________
    
                                          Signature: __________________________

                                          Name:________________________________

                                          Address:_____________________________
    
    * No shares of Common Stock will be issued until the original Series A 
Preferred Stock Certificate(s) to be converted and the Notice of Conversion are 
received by the Company or its Transfer Agent. The Holder shall (i) send via 
facsimile, on or prior to 11:59 p.m., New York City time. on the date of 
conversion, a copy of this completed and fully executed Notice of Conversion
to the Company at the office of the Company and its designated Transfer Agent 
for the Series A Preferred Stock that the Holder elects to convert and (ii) 
surrender, to a common courier for either overnight or two (2) day delivery to 
the office of the Company or the Transfer Agent, the original Series A Preferred
Stock Certificate(s) representing the Series A Preferred Stock being convened,
duly endorsed for transfer. The Company or its Transfer Agent shall issue shares
of Common Stock and surrender them to a common courier for delivery to the 
shareholder within two (2) business days following receipt of a facsimile of 
this Notice of Conversion AND receipt by the Company or its Transfer Agent of 
the original Series A Preferred Stock Certificate(s) to be convened, all in
accordance with the terms of the Certificate of Designation and the Subscription
Agreement, and shall make payments for the number of business days such issuance
and delivery is late, pursuant to the temms of the Certificate of Designation.
    
                              EXHIBIT N
<PAGE>

</TABLE>